{"Title": "New Technologies for Outcome Measures in Glaucoma: Review by the European Vision Institute Special Interest Focus Group", "Year": 2020, "Source": "Ophthalmic Res.", "Volume": "63", "Issue": 2, "Art.No": null, "PageStart": 88, "PageEnd": 96, "CitedBy": 1, "DOI": "10.1159/000504892", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85078247838&origin=inward", "Abstract": "\u00a9 2020 S. Karger AG, Basel. Copyright: All rights reserved.Glaucoma is the leading cause of irreversible blindness worldwide, with an increasing prevalence. The complexity of the disease has been a major challenge in moving the field forward with regard to both pathophysiological insight and treatment. In this context, discussing possible outcome measures in glaucoma trials is of utmost importance and clinical relevance. A recent meeting of the European Vision Institute (EVI) special interest focus group was held on \"New Technologies for Outcome Measures in Retina and Glaucoma,\" addressing both functional and structural outcomes, as well as translational hot topics in glaucoma and retina research. In conjunction with the published literature, this review summarizes the meeting focusing on glaucoma.", "AuthorKeywords": ["Glaucoma", "Neurodegeneration", "Outcome measure", "Retinal ganglion cell", "Structure-function correlation"], "IndexKeywords": ["Academies and Institutes", "Europe", "Focus Groups", "Glaucoma", "Humans", "Optic Nerve", "Outcome Assessment, Health Care", "Retinal Ganglion Cells", "Vision, Ocular"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85078247838", "SubjectAreas": [["Ophthalmology", "MEDI", "2731"], ["Sensory Systems", "NEUR", "2809"], ["Cellular and Molecular Neuroscience", "NEUR", "2804"]], "AuthorData": {"48461964400": {"Name": "Traber G.L.", "AuthorID": "48461964400", "AffiliationID": "121093025", "AffiliationName": "Institute of Molecular and Clinical Ophthalmology Basel (IOB)"}, "57208440224": {"Name": "Della Volpe-Waizel M.", "AuthorID": "57208440224", "AffiliationID": "121093025", "AffiliationName": "Institute of Molecular and Clinical Ophthalmology Basel (IOB)"}, "7006706337": {"Name": "Scholl H.P.N.", "AuthorID": "7006706337", "AffiliationID": "121093025", "AffiliationName": "Institute of Molecular and Clinical Ophthalmology Basel (IOB)"}, "6507518152": {"Name": "Maloca P.", "AuthorID": "6507518152", "AffiliationID": "121093025", "AffiliationName": "Institute of Molecular and Clinical Ophthalmology Basel (IOB)"}, "6602989710": {"Name": "Roska B.", "AuthorID": "6602989710", "AffiliationID": "121093025", "AffiliationName": "Institute of Molecular and Clinical Ophthalmology Basel (IOB)"}, "56312344200": {"Name": "Schmidt-Erfurth U.", "AuthorID": "56312344200", "AffiliationID": "60011394", "AffiliationName": "Department of Ophthalmology, Medical University of Vienna"}, "57204026504": {"Name": "Rubin G.", "AuthorID": "57204026504", "AffiliationID": "60022148, 60013148", "AffiliationName": "Institute of Ophthalmology, UCL University College London"}, "57210287162": {"Name": "Cordeiro M.F.", "AuthorID": "57210287162", "AffiliationID": "60015150", "AffiliationName": "Imperial College Ophthalmic Research Group (ICORG), Imperial College London"}, "57210375032": {"Name": "Otto T.", "AuthorID": "57210375032", "AffiliationID": "101818169", "AffiliationName": "Heidelberg Engineering GmbH"}, "7005148782": {"Name": "Weleber R.", "AuthorID": "7005148782", "AffiliationID": "60011915", "AffiliationName": "Casey Eye Institute, Departments of Ophthalmology and Molecular and Medical Genetics, University of Oregon Health, Science University"}, "6506073238": {"Name": "Lesmes L.A.", "AuthorID": "6506073238", "AffiliationID": "118823031", "AffiliationName": "Adaptive Sensory Technology, Inc."}, "6602727179": {"Name": "Arleo A.", "AuthorID": "6602727179", "AffiliationID": "60001422, 60008134, 60000905", "AffiliationName": "Institut de la Vision, CNRS, INSERM, Sorbonne Universit\u00e9"}}}